Enabling Lower-Cost Prescribing at the Point-of-Care with Kyle Kiser, CEO at RxRevu
In this Outcomes Rocket Pharma episode, we are privileged to host Kyle Kiser, CEO at RxRevu. Kyle discusses how his company provides patient-specific, real-time insights into prescribing decisions, delivering patient, provider, and health plan benefits due to lower cost and improved adherence. He also shares what makes RxRevu stand out from other companies in the pharma space. Kyle shares his thoughts on some of the challenges he has seen in both the payer and provider sides, so make sure to tune in!
Click this link to the show notes, transcript, and resources: outcomesrocket.health